Valuation: QuidelOrtho Corporation

Market Cap 1.11B 963M 899M 825M 1.55B 106B 1.58B 10.55B 4.14B 53.09B 4.18B 4.09B 176B P/E 2026 *
-
P/E 2027 * -102x
Enterprise Value 3.48B 3.01B 2.81B 2.58B 4.85B 331B 4.93B 33B 12.95B 166B 13.07B 12.79B 549B EV / Sales 2026 *
1.33x
EV / Sales 2027 * 1.25x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day-25.09%
1 week-25.86%
Current month-26.74%
1 month-31.75%
3 months+12.09%
6 months-57.78%
Current year-56.99%
1 week 11.41
Extreme 11.41
18.04
1 month 11.41
Extreme 11.41
19.03
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.6
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
-24.72%-25.86%-47.59%-85.30% 1.11B
+1.18%+4.50%+30.82%-36.21% 16.59B
+4.02%+3.13%-2.08%+105.50% 1.68B
+2.21%+0.36%-33.39%+24.93% 981M
+2.52%+4.97%-40.54%-50.80% 662M
+3.27%+1.78%-45.91%-50.88% 531M
+1.31%+12.10%+76.28%-45.31% 516M
+4.95%+10.06%-44.43%-43.45% 396M
+3.11%+2.70%-7.75%-26.02% 371M
+0.27%+25.00%+48.59% - 350M
Average -0.19%+3.30%-6.60%-23.06% 2.32B
Weighted average by Cap. +0.35%+2.77%+17.54%-26.46%

Financials

2026 *2027 *
Net sales 2.62B 2.27B 2.12B 1.94B 3.65B 249B 3.71B 24.84B 9.75B 125B 9.84B 9.63B 413B 2.72B 2.36B 2.2B 2.02B 3.8B 259B 3.86B 25.82B 10.13B 130B 10.23B 10.01B 430B
Net income -244M -211M -197M -181M -340M -23.22B -345M -2.31B -908M -11.64B -916M -896M -38.48B -91.29M -78.97M -73.74M -67.65M -127M -8.69B -129M -865M -340M -4.35B -343M -335M -14.4B
Net Debt 2.37B 2.05B 1.91B 1.76B 3.3B 225B 3.35B 22.45B 8.81B 113B 8.9B 8.7B 374B 2.3B 1.99B 1.86B 1.7B 3.2B 219B 3.25B 21.78B 8.55B 110B 8.63B 8.44B 362B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-08-07 US$12.29 -24.72% 4,888,463
26-08-06 US$16.32 -6.72% 2,749,631
26-08-05 US$17.50 -0.48% 1,212,516
26-08-04 US$17.58 -0.73% 1,181,224
26-08-03 US$17.71 +5.61% 1,381,947
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
16.32USD
Average target price
20.67USD
Spread / Average Target
+26.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock